These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 560284)

  • 1. Plasma levels of d-norgestrel and sex hormone binding globulin during oral d-norgestrel medication immediately after delivery and legal abortion.
    Nilsson S; Victor A; Nygren KG
    Contraception; 1977 Jan; 15(1):87-92. PubMed ID: 560284
    [No Abstract]   [Full Text] [Related]  

  • 2. Contraception with d-norgestrel silastic rods. Plasma levels of d-norgestrel and influence on the ovarian function.
    Weiner E; Johansson ED
    Contraception; 1976 Nov; 14(5):551-62. PubMed ID: 987891
    [No Abstract]   [Full Text] [Related]  

  • 3. Relation between sex hormone binding globulin and D-norgestrel levels in plasma.
    Victor A; Weiner E; Johansson ED
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):430-6. PubMed ID: 578629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of d-norgestrel after oral administration.
    Weiner E; Victor A; Johansson ED
    Contraception; 1976 Nov; 14(5):563-70. PubMed ID: 987892
    [No Abstract]   [Full Text] [Related]  

  • 5. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
    Miller JF; Fotherby K; Bye PG; Elstein M
    Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestagen-dependent effect on some plasma proteins during oral contraception.
    Liukko P; Erkkola R; Bergink EW
    Gynecol Obstet Invest; 1988; 25(2):118-22. PubMed ID: 2967233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR; Roy S; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does endogenous sex hormone binding globulin influence the contraceptive effect of levonorgestrel?
    Cekan SZ
    Steroids; 1988 Oct; 52(4):399-400. PubMed ID: 3150627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and percentages of non-protein bound contraceptive steroids in human serum.
    Hammond GL; Lähteenmäki PL; Lähteenmäki P; Luukkainen T
    J Steroid Biochem; 1982 Oct; 17(4):375-80. PubMed ID: 6215538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two estradiol/norgestrel combinations on the ovulatory pattern and on sex hormone binding globulin capacity in women around forty years of age.
    Hagstad A; Damber JE; Janson PO; Samsioe G; Södergård R
    Acta Obstet Gynecol Scand; 1984; 63(4):321-4. PubMed ID: 6540031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
    Jung-Hoffmann C; Kuhl H
    Am J Obstet Gynecol; 1987 Jan; 156(1):199-203. PubMed ID: 2948387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the contraceptive steroids norgestrel and norethisterone in human plasma.
    Jenkins N; Fotherby K
    J Steroid Biochem; 1980 May; 13(5):521-7. PubMed ID: 6771468
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained intrauterine release of d-norgestrel.
    Luukkainen T; Nilsson CG
    Contraception; 1978 Oct; 18(4):451-4. PubMed ID: 720077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of ethinylestradiol and D-norgestrel during two immediate postabortal oral contraceptive cycles.
    Lähteenmäki P; Nilsson CG
    Contraception; 1978 Jan; 17(1):9-17. PubMed ID: 627151
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.